Copeptin as a serum biomarker of febrile seizures

Benjamin Stöcklin1, Sotirios Fouzas2, Paula Schillinger1

  • 1Division of Pediatric Neurology and Developmental Medicine, University of Basel Children's Hospital (UKBB), Basel, Switzerland.

Plos One
|April 21, 2015
PubMed

Insights

Serum copeptin levels are significantly elevated in children experiencing febrile seizures (FS). This biomarker shows high diagnostic accuracy, aiding in the emergency diagnosis of postictal states in children.

Area of Science:

  • Pediatric Neurology
  • Biomarkers in Medicine
  • Emergency Medicine

Background:

  • Accurate diagnosis of febrile seizures (FS) in children is challenging due to the absence of reliable postictal biomarkers.
  • Serum copeptin, a marker of arginine vasopressin secretion, is investigated as a potential diagnostic tool.

Purpose of the Study:

  • To determine if serum copeptin levels are elevated in children with febrile seizures.
  • To assess the diagnostic accuracy of serum copeptin for febrile seizures.

Main Methods:

  • A prospective cross-sectional study involving 161 children (6 months to 5 years) was conducted in an emergency setting.
  • Serum copeptin and prolactin levels were measured in children with febrile seizures (n=83), febrile infection without seizures (n=69), and non-febrile epileptic seizures (n=9).

Main Results:

  • Serum copeptin was significantly higher in children with febrile seizures compared to febrile controls (p < 0.001).
  • Seizures were the primary determinant of serum copeptin levels (beta 0.509; p < 0.001).
  • Copeptin demonstrated superior diagnostic accuracy (AUC 0.824) compared to prolactin (AUC 0.667), with accuracy increasing as the time since seizure decreased.

Conclusions:

  • Circulating copeptin exhibits high diagnostic accuracy for febrile seizures.
  • Serum copeptin may serve as a valuable adjunct biomarker for diagnosing postictal states in emergency settings.
Abstract